Ray Blind, Ph.D.
Assistant Professor, Departments of Medicine, Biochemistry and Pharmacology
- : 615-936-1037
- :
8405 MRBIV
- : More Information/Publications
Areas of Interest: Cancer Biology: Cell Signaling; Protein Structure & Function; Natural Products; Synthetic & Medicinal Chemistry; High-Throughput Technology; Nanotechnology; Imaging
Member: Vanderbilt Diabetes Research and Training Center (DRTC); CSB; VICC
The Blind Lab is focused on exploring the structure, function and signaling properties of nuclear inositide lipids and soluble inositol phosphates. Our group uses genomics, structural biology and chemical genetics to determine new mechanisms of nuclear signaling. We then use of that new signaling information to develop novel drug discovery platforms, with potential in several cancers (glioblastoma and hepatocellular carcinoma) and metabolic liver diseases (fatty liver, hepatosteatosis and type II diabetes).